Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About UBS Interactive Breakdown Better Bets vs. UBS Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

UBS (UBS)

Market Price (10/26/2025): $38.03 | Market Cap: $120.9 Bil
Sector: Financials | Industry: Diversified Banks

UBS (UBS)

Market Price (10/26/2025): $38.03
Market Cap: $120.9 Bil
Sector: Financials
Industry: Diversified Banks

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.2%, FCF Yield is 8.4%		  Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 84%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 27%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 12 Bil, FCF LTM is 10 Bil		  
2 Low stock price volatility
Vol 12M is 30%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.2%, FCF Yield is 8.4%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 27%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 12 Bil, FCF LTM is 10 Bil
2 Low stock price volatility
Vol 12M is 30%
3 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 84%

Market Valuation & Key Metrics

UBSS&P 500
REVENUE GROWTHPOOR
Rev LTM ($ Bil)45.4
Rev Chg Q3.8%6.4%
Rev Chg LTM3.0%5.3%
Rev Chg 3Y Avg9.7%5.4%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)�
CFO LTM ($ Bil)12.3
Net Inc LTM ($ Bil)6.3
CFO/Rev LTM27.1%20.5%
Net Inc Mgn13.8%12.7%
VALUATIONMODERATE
P/S2.73.3
P/CFO9.816.1
P/FCF12.020.9
P/E19.224.0

UBS Stock

   
   
   
   
   
   
   

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
UBS Return19%28%6%70%1%29%257%
Peers Return4%35%-15%17%42%33%161%
S&P 500 Return16%27%-19%24%23%15%110%

Monthly Win Rates [3]
UBS Win Rate58%67%58%58%50%78% 
Peers Win Rate58%63%42%50%65%69% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
UBS Max Drawdown-39%0%-21%-3%-13%-14% 
Peers Max Drawdown-47%-2%-29%-14%-4%-18% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: JPM, BAC, MS, GS, C. See UBS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/24/2025 (YTD)

How Low Can It Go

Unique KeyEventUBSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-34.3%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven52.3%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven98 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-42.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven75.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven238 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-51.4%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven105.6%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven909 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-79.5%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven388.4%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven5800 days1480 days

Compare to JPM, BAC, MS, GS, C


In The Past

UBS's stock fell -34.3% during the 2022 Inflation Shock from a high on 2/9/2022. A -34.3% loss requires a 52.3% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About UBS (UBS)

Interactive Breakdown

UBS Interactive Breakdown Analysis

Better Bets than UBS (UBS)

 UBSBetter Performance than UBS
MetricValueIndustry (Diversified Banks)
Rev Chg LTM3.0%JPM (8.2%), BAC (5.4%), HSBC (6.9%), RY (16.4%), C (6.3%)
Rev Chg 3Y Avg9.7%JPM (13.5%), RY (9.9%), TD (10.6%), BMO (10.2%)
CFO/Rev LTM27.1%RY (135.4%), TD (32.4%), BNS (52.2%), CM (61.6%), PNC (27.4%)
FCF/Rev LTM22.3%RY (131.7%), TD (28.7%), BNS (51.3%), CM (57.6%), USB (27.0%)
Total Yield5.2%JPM (6.7%), BAC (6.9%), WFC (9.3%), HSBC (8.1%), RY (9.2%)
 UBSBetter Performance than UBS
MetricValueAll Other Sectors
Rev Chg LTM3.0%NVDA (71.6%), AAPL (6.0%), MSFT (14.9%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg9.7%NVDA (92.0%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%), META (13.0%)
CFO/Rev LTM27.1%NVDA (46.6%), MSFT (48.3%), GOOGL (36.0%), META (56.4%), AVGO (42.4%)
FCF/Rev LTM22.3%NVDA (43.6%), AAPL (23.5%), MSFT (25.4%), META (30.7%), AVGO (41.6%)
Total Yield5.2%XOM (9.7%), JNJ (8.1%), BABA (36.1%), HD (6.2%), UNH (8.8%)
 Best Bets In Financials Sector
 UBSDBRG OTF MTG NMIH ENVA ACGL APAM EEFT FAF KMPR
What You Pay           
P/E19.239.813.38.57.610.68.710.510.513.68.9
P/EBIT�64.99.26.45.68.27.76.16.38.26.5
What You Get           
Rev Chg Q3.8%-102.4%1,228.5%-0.3%7.2%16.3%22.4%4.4%8.9%40.7%7.8%
Rev Chg LTM3.0%-84.8%89.0%3.3%10.0%21.1%23.5%10.0%8.7%20.7%2.6%
Rev Chg 3Y Avg9.7%125.8%221.9%1.2%10.1%23.5%29.8%0.2%9.1%-3.3%-4.7%
FCF/Rev 3Y Avg78.9%101.2%76.2%59.8%58.8%54.7%38.4%29.0%15.9%7.0%2.0%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 21%, alpha of 9.1%, and sharpe of 0.94

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1UBS Stock Lost 9.6%, Buy Or Wait?Return 
2UBS Dip Buy Analysis  
3UBS Total Shareholder Return (TSR): 2.4% in 2024 and 23.9% 3-yr compounded annual returns (above peer average)  
4Time To Buy UBS Stock?Buy or Fear 
5UBS (UBS) Operating Cash Flow ComparisonFinancials 
6UBS (UBS) Net Income ComparisonFinancials 
7Fundamental Metrics: ...  
8UBS (UBS) Stock Has 49% Chance Of Rise In The Next One Month  
9Dates Cached For UBS  
10UBS (UBS) Stock Has 81% Chance Of Rise In The Next One Month  
11ARTICLES  
12Large Cap Stocks Trading At 52-Week High July 23rd, 2025
13Large Cap Stocks Trading Near 52W High July 10th, 2025
14Large Cap Stocks Trading Near 52W High July 9th, 2025
15UBS Stock Is Up 4.5% Since The Q1 Results, What To Expect Next? May 9th, 2024
16Up 50% In The Last 12 Months, Where Is UBS Stock Headed? April 8th, 2024

Trade Ideas

Select past ideas related to UBS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-11.9%-11.9%-12.7%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		8.7%8.7%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		4.3%4.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-1.3%-1.3%-4.9%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		14.3%14.3%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
HLNE_9302025_Dip_Buyer_FCFYield09302025HLNEHamilton LaneDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-11.9%-11.9%-12.7%
CNS_9302025_Dip_Buyer_ValueBuy09302025CNSCohen & SteersDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		8.7%8.7%-1.6%
JKHY_9262025_Monopoly_xInd_xCD_Getting_Cheaper09262025JKHYJack Henry & AssociatesMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		4.3%4.3%-2.1%
FDS_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025FDSFactSet Research SystemsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-1.3%-1.3%-4.9%
IBKR_9052025_Quality_Momentum_RoomToRun_10%09052025IBKRInteractive BrokersQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		14.3%14.3%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1498.4%344.0%
2PRAXPraxis Precision Medicines253.2%126.1%
3NVTSNavitas Semiconductor116.1%294.1%
4SNDKSanDisk97.4% 
5UAMYUnited States Antimony90.3%578.5%
6GRALGRAIL85.2%400.8%
7BALYBallys82.9%6.8%
8ORKAOruka Therapeutics81.1%40.5%
9INBXInhibrx Biosciences79.9%272.0%
10CIFRCipher Mining77.2%345.3%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1VGVenture Global-35.7% 
2PMIPicard Medical-35.3%8328.6%
3SOCSable Offshore-33.7%-41.7%
4FWRDForward Air-28.9%-39.0%
5FLYFirefly Aerospace-28.5% 
6ITGRInteger-28.4%-45.0%
7USNAUsana Health Sciences-26.5%-42.0%
8HTZHertz Global-26.3%41.5%
9RCReady Capital-25.1%-50.3%
10ULHUniversal Logistics-24.8%-61.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for UBS

Financials

UBSJPMBACMSGSCMedian
NameUBS JPMorgan.Bank of .Morgan S.Goldman .Citigroup 
Mkt Price38.02300.4452.57163.86783.8898.78131.32
Mkt Cap120.9837.8403.6258.4245.9183.3252.2
Rev LTM45,406175,656103,43561,50356,21383,11372,308
Op Inc LTM-------
FCF LTM10,106-148,6154,550-20,941-24,879-93,686-22,910
FCF 3Y Avg33,683-56,10424,365-25,282-27,212-65,690-26,247
CFO LTM12,310-148,6154,550-17,670-22,852-87,165-20,261
CFO 3Y Avg35,578-56,10424,365-21,957-24,836-59,182-23,396

Growth & Margins

UBSJPMBACMSGSCMedian
NameUBS JPMorgan.Bank of .Morgan S.Goldman .Citigroup 
Rev Chg LTM3.0%8.2%5.4%16.7%12.2%6.3%7.2%
Rev Chg 3Y Avg9.7%13.5%5.0%5.0%3.8%4.3%5.0%
Rev Chg Q3.8%6.7%6.0%11.3%14.5%8.1%7.4%
QoQ Delta Rev Chg LTM0.9%1.6%1.5%2.6%3.4%2.0%1.8%
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM27.1%-84.6%4.4%-28.7%-40.7%-104.9%-34.7%
CFO/Rev 3Y Avg83.6%-32.5%24.8%-41.3%-46.4%-74.6%-36.9%
FCF/Rev LTM22.3%-84.6%4.4%-34.0%-44.3%-112.7%-39.2%
FCF/Rev 3Y Avg78.9%-32.5%24.8%-47.4%-51.2%-82.8%-40.0%

Valuation

UBSJPMBACMSGSCMedian
NameUBS JPMorgan.Bank of .Morgan S.Goldman .Citigroup 
Mkt Cap120.9837.8403.6258.4245.9183.3252.2
P/S2.74.83.94.24.42.24.1
P/EBIT-------
P/E19.214.814.517.515.812.915.3
P/CFO9.8-5.688.7-14.6-10.8-2.1-3.9
Total Yield5.2%6.7%6.9%5.7%6.3%7.7%6.5%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg37.3%-7.4%8.7%-16.0%-14.8%-56.0%-11.1%
D/E2.90.60.91.41.52.01.4
Net D/E0.8-0.5-0.80.90.8-1.00.2

Returns

UBSJPMBACMSGSCMedian
NameUBS JPMorgan.Bank of .Morgan S.Goldman .Citigroup 
1M Rtn-6.1%-3.7%1.4%3.1%-1.4%-3.3%-2.3%
3M Rtn-1.0%1.1%9.1%14.6%8.1%3.5%5.8%
6M Rtn26.6%24.6%34.0%43.4%45.4%46.5%38.7%
12M Rtn22.2%38.0%28.4%44.4%56.0%64.9%41.2%
3Y Rtn155.7%160.6%59.4%124.9%152.2%144.0%148.1%
1M Excs Rtn-8.9%-6.5%-1.4%0.3%-4.2%-6.1%-5.1%
3M Excs Rtn-5.7%-5.1%3.3%8.7%2.6%-2.9%-0.1%
6M Excs Rtn3.7%1.6%11.1%20.4%22.4%23.5%15.7%
12M Excs Rtn4.7%20.8%11.1%26.6%38.3%44.1%23.7%
3Y Excs Rtn96.3%93.9%-16.0%50.6%87.7%71.8%79.8%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date7/30/20254/29/20252/4/202510/30/20248/14/20245/7/20242/6/202411/7/20238/31/20234/25/20231/31/202310/25/2022
Key Financials Quarterly            
Total Revenue11,49911,38311,06011,46411,07311,94110,41710,6449,5098,6987,9887,956
Net Income2,3951,6927701,4251,1351,755-279-71527,3311,0291,6531,733
EPS0.750.530.240.450.350.55-0.09-0.228.870.330.530.54
Key Financials TTM            
Total Revenue TTM45,40644,98045,53844,89544,07542,51139,26836,83934,15132,70933,39334,121
Net Income TTM6,2825,0225,0854,0361,89628,09227,36629,29831,7466,5237,6307,325
Growth Rates Quarterly            
Total Revenue Growth3.8%-4.7%6.2%7.7%16.4%37.3%30.4%33.8%17.9%-7.3%-8.4%-11.7%
Net Income Growth111.0%-3.6%376.0%299.3%-95.8%70.6%-116.9%-141.3%1196.5%-51.8%22.6%-24.0%
Margins Quarterly            
Net Income Margin20.8%14.9%7.0%12.4%10.3%14.7%-2.7%-6.7%287.4%11.8%20.7%21.8%
Cash & Debt            
Total Cash245,655237,043227,900248,762253,793276,736319,357267,944267,621149,201175,064171,278
Total Debt347,708336,145332,423350,563354,626354,677377,685362,550369,421198,648193,276184,268
Net Debt / (Cash)102,05399,102104,523101,801100,83377,94158,32894,606101,80049,44718,21212,990
Cash Flows Quarterly            
FCF from Operations5,51215,377-12,6824,10331411,54437,93730,46642,771-25,106-353-3,150
Cash Flows TTM            
FCF from Operations TTM12,3107,1123,27953,89880,261122,71886,06847,77814,162-37,73814,64725,133
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-02,1911,261-0
Return on Invested Capital (ROIC) Quarterly            
ROIC8.2%6.8%3.0%5.4%4.6%8.6%-1.7%-0.7%102.7%8.4%36.4%48.7%
Return on Invested Capital (ROIC) TTM            
ROIC TTM5.9%5.1%4.9%3.9%1.9%34.4%42.3%29.7%29.9%13.3%42.1%51.4%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Global Wealth Management21,55618,96719,41917,13416,373
Investment Bank8,7038,7179,4549,5197,299
Personal & Corporate Banking7,6874,3024,2633,9073,736
Asset Management2,6862,9612,6172,9761,937
Non-core and Legacy69723760  
Group Items-495-622-419-451-377
Total40,83434,56235,39433,08528,968


Assets by Segment
$ Mil20242023202220212020
Global Wealth Management567,648388,530395,235367,714309,766
Personal & Corporate Banking483,794235,226225,370231,657209,405
Investment Bank428,269391,320346,431369,683315,855
Non-core and Legacy201,13113,36725,153  
Asset Management21,80417,34825,63928,58934,565
Group Items14,27758,57499,354128,122102,603
Total1,716,9231,104,3651,117,1821,125,765972,194


Price Behavior

UBS Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta2.201.451.571.071.061.08
Up Beta2.311.591.310.971.011.08
Down Beta2.821.301.561.010.980.94
Up Capture153%157%204%158%142%187%
Bmk +ve Days13233574144420
Stock +ve Days12253775139407
Down Capture283%132%136%116%106%101%
Bmk -ve Days8192952107330
Stock -ve Days9172650110339

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity9,398,049
Short Interest: % Change Since 930202518.4%
Average Daily Volume1,677,550
Days-to-Cover Short Interest5.60
Basic Shares Quantity3,179,288,753
Short % of Basic Shares0.3%

Returns Analyses

SEC Filings

Expand for More

Report DateFiling DateFiling
331202142720216-K 3/31/2021
12312020305202120-F 12/31/2020
9302020102020206-K 9/30/2020
630202072120206-K 6/30/2020
331202042820206-K 3/31/2020
12312019303202020-F 12/31/2019
9302019102220196-K 9/30/2019
630201972320196-K 6/30/2019
331201942520196-K 3/31/2019
12312018315201920-F 12/31/2018
9302018102520186-K 9/30/2018
630201872420186-K 6/30/2018
331201842320186-K 3/31/2018
12312017309201820-F 12/31/2017
9302017102720176-K 9/30/2017
630201772820176-K 6/30/2017

Insider Activity

Expand for More

 

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.